Products Mirabegron is commercially available in the form of sustained-release film-coated tablets (Betmiga, USA: Myrbetriq). It was approved in the US and EU in 2012 and in many countries in 2014. Mirabegron was the first agent from the beta3 agonist group to be approved for the treatment of irritable bladder. It was originally intended to … Mirabegron
Symptoms Irritable bladder manifests itself in the following symptoms. By definition, there are no pathologic changes of the genitourinary tract: Strong urge to urinate, which is difficult to suppress. Increased urinary frequency during the day Nighttime urination Urinary incontinence: an involuntary loss of urine may occur The constant urge reduces the quality of life and … Hyperactive Bladder
